Lymphocyte-Rich Classic Hodgkin Lymphoma
2 clinical trials · Condition
◉ Watch Lymphocyte-Rich Classic Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma (NCT03907488) | National Cancer Institute (NCI) | 2019-08-29 |
| Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma (NCT03712202) | City of Hope Medical Center | 2018-11-28 |
Track Lymphocyte-Rich Classic Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.